Figure 3
From: The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer
Kaplan-Meier plot of overall survival based on Cx26 expression after chemotherapy. Log-rank test reveals significant association (p=0.011) between reduced Cx26 expression (0; <5%) and improved disease outcome.